Centrally administered angiotensin-(1-7) increases the survival of stroke-prone spontaneously hypertensive rats

Experimental Physiology

Volumn 99, Issue 2, 2014, Pages 442-453

  Regenhardt, Robert W ^a   Mecca, Adam P ^a   Desland, Fiona ^a   Ritucci Chinni, Phillip F ^a   Ludin, Jacob A ^a   Greenstein, David ^a   Banuelos, Cristina ^a,b   Bizon, Jennifer L ^a,b   Reinhard, Mary K ^a   Sumners, Colin ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CORTICOSTERONE; SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BRAIN HEMORRHAGE; CELL COUNT; CELL SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; HEART DISEASE; HIGH SODIUM INTAKE; HYPERTENSION; KIDNEY DISEASE; LETHARGY; MALE; MICROGLIA; NERVE CELL; NONHUMAN; RAT; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL RATE;

ANGIOTENSIN I; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CORPUS STRIATUM; CORTICOSTERONE; HEART; HYPERTENSION; INFUSIONS, INTRAVENTRICULAR; KIDNEY; MALE; MICROGLIA; PEPTIDE FRAGMENTS; RATS; RATS, INBRED SHR; STROKE;

EID: 84893373799     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.075242     Document Type: Article

References (26)

1. Bruijnzeel AW, Rodrick G, Singh RP, Derendorf H & Bauzo RM (2011). Repeated pre-exposure to tobacco smoke potentiates subsequent locomotor responses to nicotine and tobacco smoke but not amphetamine in adult rats. Pharmacol Biochem Behav 100, 109-118.
2. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group (2002). Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 995-1003.
3. Enzmann DR, Britt RH, Lyons BE, Buxton JL & Wilson DA (1981). Natural history of experimental intracerebral hemorrhage: sonography, computed tomography and neuropathology. AJNR Am J Neuroradiol 2, 517-526.
4. Gong C, Hoff JT & Keep RF (2000). Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res 871, 57-65.
5. Gong Y, Hua Y, Keep RF, Hoff JT & Xi G (2004). Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke 35, 2571-2575.
6. Gonzales CL & Kolb B (2003). A comparison of different models of stroke on behavior and brain morphology. Eur J Neurosci 18, 1950-1962.
7. Groth W, Blume A, Gohlke P, Unger T & Culman J (2003). Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21, 2175-2182.
8. Iadecola C & Davisson RL (2008). Hypertension and cerebrovascular dysfunction. Cell Metab 7, 476-484.
9. Jiang T, Gao L, Guo J, Lu J, Wang Y & Zhang Y (2012). Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia. Br J Pharmacol 167, 1520-1532.
10. Jokinen MP, Lieuallen WG, Boyle MC, Johnson CL, Malarkey DE & Nyska A (2011). Morphologic aspects of rodent cardiotoxicity in a retrospective evaluation of National Toxicology Program studies. Toxicol Pathol 39, 850-860.
11. Lyden PD & Zivin JA (1993). Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Metab Rev 5, 1-16.
12. Marks L, Carswell HV, Peters EE, Graham DI, Patterson J, Dominiczak AF & Macrae IM (2001). Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension 38, 116-122.
13. Mecca AP, O'Connor TE, Katovich MJ & Sumners C (2009). Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion. Exp Physiol 94, 937-946.
14. Mecca AP, Regenhardt RW, O'Connor TE, Joseph JP, Raizada MK, Katovich MJ & Sumners C (2011). Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp Physiol 96, 1084-1096.
15. Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P & Zanchetti A (2004). Study on Cognition and Prognosis in the Elderly study group. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). J Am Coll Cardiol 44, 1175-80.
16. Regenhardt RW, Desland F, Mecca AP, Pioquinto DJ, Afzal A, Mocco J & Sumners C (2013). Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke. Neuropharmacology 71, 154-163.
17. Reinhard MK, Hottendorf GH & Powell ED (1991). Differences in the sensitivity of Fischer and Sprague-Dawley rats to aminoglycoside nephrotoxicity. Toxicol Pathol 19, 66-71.
18. Santos RAS, Ferreira AJ & Simões e Silva AC (2008). Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 93, 519-527.
19. Smeda JS (1989). Hemorrhagic stroke development in spontaneously hypertensive rats fed a North American, Japanese-style diet. Stroke 20, 1212-1218.
20. Smeda JS (1992). Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol 70, 552-564.
21. Smith SC Jr (2011). Reducing the global burden of ischemic heart disease and stroke: a challenge for the cardiovascular community and the United Nations. Circulation 124, 278-279.
22. Sterio DC (1984). The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134, 127-136.
23. Thöne-Reineke C, Steckelings UM & Unger T (2006). Angiotensin receptor blockers and cerebral protection in stroke. J Hypertens Suppl 24, S115-S121.
24. Wang J & Tsirka SE (2005a). Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 128, 1622-1633.
25. Wang J & Tsirka SE (2005b). Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 36, 613-618.
26. West MJ, Slomianka L & Gundersen HJ (1991). Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231, 482-497.